Shire Health International bags Abilify brief
PR Week UK, Thursday, 29 June 2006, 12:00am,
Bristol-Myers Squibb and Otsuka have switched the pan-European account for schizophrenia drug Abilify from Ogilvy PR Worldwide to sister WPP agency Shire Health International.
The appointment will see Shire Health advising on comms surrounding the 19th congress of the European College of Neuropsychopharmacology in Paris this September. Shire Health won the work after what is understood to have been a three-way pitch in which BMS’s procurement staff were closely involved.
Ogilvy, which said it did not repitch, launched Abilify in Europe in June 2004 and promoted the brand until its final task: handling media relations surrounding the 14th European Congress of Psychiatry in Nice, France, in March.
Shire Health reports to BMS associate director of business and corporate communications EMEA Tessa Lush, and Otsuka senior comms manager, Europe, Alison Ross. Both are based in the UK.
Pope Woodhead continues to handle UK PR for the brand.
Share this story
Additional Information
Latest jobs Jobs web feed
-
Online PR Manager- Exciting Online Content Marketing Co- up to £45,000
Cedar Scott
Up to £45,000 per annum, Central London -
In-House Retail Brand - Internal Communication Manager
6 Degrees Talent Ltd
c£55k, Milton Keynes -
Property PR & marketing Account Manager
Halogen
£32,500 - £37,500, Central London -
Senior Account Director - Consumer Health
PR Futures
£55-£65k+package + bonus, London -
Director of Media Relations
British Bankers' Association
Competitive Salary + benefits, City of London
Most read
- PR agencies claw back digital business from specialist shops
- Google 'on front foot' with Eric Schmidt column on tax issue
- NHS leaders and chief executives encouraged to communicate online
- Hope&Glory wins Ikea consumer press office duties
- Ad agency BMB enters PR with ex-Independent editor Simon Kelner
- Bell Pottinger joins APPC fold after years of opposition
Most commented
